ES2314175T3 - Preparacion y metodo para la reduccion de peso. - Google Patents

Preparacion y metodo para la reduccion de peso. Download PDF

Info

Publication number
ES2314175T3
ES2314175T3 ES03702672T ES03702672T ES2314175T3 ES 2314175 T3 ES2314175 T3 ES 2314175T3 ES 03702672 T ES03702672 T ES 03702672T ES 03702672 T ES03702672 T ES 03702672T ES 2314175 T3 ES2314175 T3 ES 2314175T3
Authority
ES
Spain
Prior art keywords
trypsin
amino acids
essential amino
preparation
trypsin inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03702672T
Other languages
English (en)
Spanish (es)
Inventor
Pia Heino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REMEDAL Oy
Original Assignee
REMEDAL Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REMEDAL Oy filed Critical REMEDAL Oy
Application granted granted Critical
Publication of ES2314175T3 publication Critical patent/ES2314175T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
ES03702672T 2002-02-20 2003-02-12 Preparacion y metodo para la reduccion de peso. Expired - Lifetime ES2314175T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020332 2002-02-20
FI20020332A FI109970B (fi) 2002-02-20 2002-02-20 Valmiste ja menetelmä painon pudottamiseksi

Publications (1)

Publication Number Publication Date
ES2314175T3 true ES2314175T3 (es) 2009-03-16

Family

ID=8563269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03702672T Expired - Lifetime ES2314175T3 (es) 2002-02-20 2003-02-12 Preparacion y metodo para la reduccion de peso.

Country Status (11)

Country Link
US (1) US20050096266A1 (https=)
EP (1) EP1482976B1 (https=)
JP (1) JP2005523284A (https=)
CN (1) CN1729017A (https=)
AT (1) ATE405290T1 (https=)
AU (1) AU2003205795A1 (https=)
CA (1) CA2476771A1 (https=)
DE (1) DE60323062D1 (https=)
ES (1) ES2314175T3 (https=)
FI (1) FI109970B (https=)
WO (1) WO2003070276A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080268038A1 (en) * 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
EP2067411A1 (en) * 2007-11-29 2009-06-10 Paolo Oddenino Paris S.R.L. Food composition usable as substitute meal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB652237A (en) * 1945-12-27 1951-04-18 Merck & Co Inc Therapeutic amino acid mixtures
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
JPH0623113B2 (ja) * 1986-01-31 1994-03-30 浩 前田 癌性胸・腹水貯留抑制剤
JPH02250823A (ja) * 1989-03-24 1990-10-08 Tsumura & Co マイクロカプセル剤およびその製造方法
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
ES2087027B1 (es) * 1994-08-03 1997-02-01 Univ Illes Balears Suplementos nutricionales termogeneticos, alimentos que los contienen y aplicaciones.
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
JP2002154976A (ja) * 2000-11-22 2002-05-28 Sanpo Kk 慢性疾患の予防、改善及び／又は治療剤並びに健康食品

Also Published As

Publication number Publication date
EP1482976A1 (en) 2004-12-08
DE60323062D1 (de) 2008-10-02
WO2003070276A1 (en) 2003-08-28
AU2003205795A1 (en) 2003-09-09
FI20020332A0 (fi) 2002-02-20
JP2005523284A (ja) 2005-08-04
EP1482976B1 (en) 2008-08-20
CA2476771A1 (en) 2003-08-28
CN1729017A (zh) 2006-02-01
FI109970B (fi) 2002-11-15
ATE405290T1 (de) 2008-09-15
US20050096266A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
JP2002161050A (ja) 生活の質を改善する新規医薬組成物ならびに新規食品の製法および用途
US20050226906A1 (en) Nutrient system for individualized responsive dosing regimens
CN103404865B (zh) 一种减肥降脂营养代餐粉及其制备方法
US7138134B2 (en) Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
JP2014524743A (ja) 多成分栄養系
ES2314175T3 (es) Preparacion y metodo para la reduccion de peso.
CN111346158A (zh) 一种中药组合物在治疗胃肠功能紊乱中的用途
JP4858889B2 (ja) 栄養剤、消化器剤
JP2010248219A (ja) 生活の質を改善する新規医薬組成物ならびに新規食品の製法および用途
Costa et al. The nutritional effects of cancer and its therapy
US7998476B2 (en) Method of treatment using Aspergillus oryzae protease
US20100016210A1 (en) Sensotherapy
CN101415414B (zh) 瓜氨酸在制备治疗矫正脓毒症患者中精氨酸缺乏的药物中的用途
RU2335927C2 (ru) Обогащенные лейцином питательные композиции
WO2001064211A1 (en) Specific therapeutic composition for treating aids
JP2005272309A (ja) 魚類用薬剤
JP2518636B2 (ja) 重症感染症及び広範囲熱症治療経腸栄養剤
CN104855966A (zh) 儿童非全营养配方食品
US11813363B1 (en) Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
JP2005239737A (ja) 生活の質を改善する新規医薬組成物の製法および用途
KR20110131140A (ko) 오미자 효소의 호르몬 치유와 프로테인 식이요법
CN111011850A (zh) 一种含有植物甾醇的组合物的用途
Jones et al. Gastrointestinal Function and Toxicology in Minipigs
Chai Introductory Chapter: Stomach-Beyond Digestion
RU2274466C1 (ru) Препарат "аскохол" для коррекции массы тела при ожирении